1. Buffon, Marjoriê Piuco, Sortica, Denise Alves, Gerchman, Fernando, Crispim, Daisy, Canani, Luís Henrique. 2015. FRMD3 gene: its role in diabetic kidney disease. A narrative review. In Diabetology & metabolic syndrome, 7, 118. doi:10.1186/s13098-015-0114-4. https://pubmed.ncbi.nlm.nih.gov/26719775/
2. Chen, Yun, Hong, Chaojin, Zhou, Qihao, Qin, Zhiquan. 2022. Roles of Cadherin2 in Thyroid Cancer. In Frontiers in oncology, 12, 804287. doi:10.3389/fonc.2022.804287. https://pubmed.ncbi.nlm.nih.gov/35756646/
3. Shao, Wenjun, Li, Jiawei, Piao, Qianling, Bao, Yongli, Sun, Luguo. 2023. FRMD3 inhibits the growth and metastasis of breast cancer through the ubiquitination-mediated degradation of vimentin and subsequent impairment of focal adhesion. In Cell death & disease, 14, 13. doi:10.1038/s41419-023-05552-2. https://pubmed.ncbi.nlm.nih.gov/36631457/
4. Chen, Tzu-Ju, Chou, Chia-Lin, Tian, Yu-Feng, Li, Chien-Feng, Lai, Hong-Yue. 2021. High FRMD3 expression is prognostic for worse survival in rectal cancer patients treated with CCRT. In International journal of clinical oncology, 26, 1689-1697. doi:10.1007/s10147-021-01944-6. https://pubmed.ncbi.nlm.nih.gov/34043102/